Literature DB >> 14693571

In vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae.

M D Kitzis, A Ly, F W Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14693571      PMCID： PMC310209          DOI： 10.1128/AAC.48.1.366-367.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics.

Authors:  F W Goldstein
Journal:  J Antimicrob Chemother       Date:  1999-08       Impact factor: 5.790

2.  In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria.

Authors:  H W Boucher; C B Wennersten; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

3.  The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.

Authors:  G C Schito; E A Debbia; A Marchese
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

Review 4.  [Staphylococci resistant to antibiotic therapy].

Authors:  R Leclercq
Journal:  Ann Fr Anesth Reanim       Date:  2002-05

5.  In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

Authors:  P J Petersen; N V Jacobus; W J Weiss; P E Sum; R T Testa
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain.

Authors:  Carmen Betriu; Iciar Rodríguez-Avial; Blas Ali Sánchez; María Gómez; Juan Alvarez; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 7.  Glycylcyclines: third-generation tetracycline antibiotics.

Authors:  I Chopra
Journal:  Curr Opin Pharmacol       Date:  2001-10       Impact factor: 5.547

8.  Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus.

Authors:  J L Mainardi; D M Shlaes; R V Goering; J H Shlaes; J F Acar; F W Goldstein
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226
  8 in total
  5 in total

1.  Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.

Authors:  Radosław Izdebski; Ewa Sadowy; Janusz Fiett; Paweł Grzesiowski; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

2.  Gram-positive cocci infections in intensive care: guide to antibacterial selection.

Authors:  Francisco Alvarez-Lerma; Santiago Grau; Maria-Pilar Gracia-Arnillas
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.

Authors:  Steven D Brown; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

Review 4.  Antibiotics for treatment of resistant gram-positive coccal infections.

Authors:  Hossam Al-Tatari; Nahed Abdel-Haq; Pimpanada Chearskul; Basim Asmar
Journal:  Indian J Pediatr       Date:  2006-04       Impact factor: 5.319

5.  Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents.

Authors:  Po-Ren Hsueh; Wen-Huei Chen; Lee-Jene Teng; Kwen-Tay Luh
Journal:  Int J Antimicrob Agents       Date:  2005-07       Impact factor: 5.283
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.